CHAMPIONS ONCOLOGY, INC. (CSBR) Gross margin 2020–2026
CHAMPIONS ONCOLOGY, INC. (CSBR) gross margin by fiscal year — reported gross profit divided by reported revenue.
48.0%FY2026 · since FY2020: 47.1% → 48.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 48.0% | -2.1 pp |
| FY2025 | 50.1% | +8.8 pp |
| FY2024 | 41.4% | -3.8 pp |
| FY2023 | 45.2% | -6.7 pp |
| FY2022 | 51.9% | +4.1 pp |
| FY2021 | 47.7% | +0.7 pp |
| FY2020 | 47.1% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CSBR financial trends
CSBR RevenueCSBR Net incomeCSBR Net marginCSBR Gross profitCSBR Operating incomeCSBR Operating marginCSBR Operating cash flowCSBR Free cash flowCSBR Capital expendituresCSBR Return on equityCSBR Stock buybacksCSBR Dividends paidCSBR Total assetsCSBR Total liabilitiesCSBR Shareholders’ equityCSBR overview →